Droxidopa

What is Droxidopa?

Droxidopa is a synthetic amino acid medication primarily used to treat certain forms of orthostatic hypotension. It acts as a prodrug, meaning it is converted into an active substance in the body. Specifically, it is converted into norepinephrine, a crucial neurotransmitter responsible for regulating blood pressure and other bodily functions. This medication is particularly vital for individuals suffering from conditions that impair the body's natural ability to produce sufficient norepinephrine, leading to significant drops in blood pressure upon standing.

Its main indication is for the treatment of symptomatic neurogenic orthostatic hypotension (NOH). NOH is a chronic condition characterized by a significant drop in blood pressure when a person stands up, leading to symptoms like dizziness, lightheadedness, fainting, and fatigue. This condition often arises from underlying neurological disorders such as Parkinson's disease, multiple system atrophy, pure autonomic failure, and dopamine beta-hydroxylase deficiency. In the United States, Droxidopa is marketed under the brand name Northera.

How Does it Work?

The therapeutic action of Droxidopa hinges on its conversion to norepinephrine (also known as noradrenaline) within the body. After oral administration, Droxidopa is absorbed and then decarboxylated by the enzyme L-amino acid decarboxylase, primarily in the peripheral nervous system, to form norepinephrine. Norepinephrine is a potent neurotransmitter that acts on alpha-1 adrenergic receptors located on blood vessels. When norepinephrine binds to these receptors, it causes vasoconstriction, meaning the blood vessels narrow. This narrowing increases peripheral vascular resistance, which in turn helps to raise blood pressure.

In patients with neurogenic orthostatic hypotension, there is an impairment in the autonomic nervous system's ability to release norepinephrine in response to changes in posture. This deficiency prevents the blood vessels from constricting adequately when standing, leading to blood pooling in the lower extremities and a subsequent drop in blood pressure to the brain. By providing an exogenous source of norepinephrine, Droxidopa helps to restore the body's ability to maintain adequate blood pressure upon standing, thereby alleviating the debilitating symptoms associated with NOH.

Medical Uses

Droxidopa's primary and most critical medical use is the treatment of symptomatic orthostatic hypotension in adult patients with underlying neurological conditions. These conditions include:

• Parkinson's Disease: A progressive neurodegenerative disorder affecting movement.
• Multiple System Atrophy (MSA): A rare, progressive neurodegenerative disorder affecting autonomic functions, movement, and balance.
• Pure Autonomic Failure (PAF): A rare disorder characterized by severe orthostatic hypotension and other autonomic dysfunctions.
• Dopamine Beta-Hydroxylase Deficiency: A rare genetic disorder leading to an inability to synthesize norepinephrine.
• Non-Diabetic Autonomic Neuropathy: Nerve damage affecting autonomic functions, not caused by diabetes.

The goal of Droxidopa therapy is to alleviate the symptoms of orthostatic hypotension, such as dizziness, lightheadedness, fatigue, and fainting, which significantly impact a patient's quality of life and increase the risk of falls and injuries. It is not intended to treat the underlying neurological disease itself but rather to manage one of its most troublesome symptoms.

Dosage

Droxidopa is administered orally, typically in capsule form. The dosage must be carefully individualized and titrated by a healthcare professional to achieve the desired therapeutic effect while minimizing side effects, particularly hypertension. The usual starting dose for adults is 100 mg three times daily. This dose is then gradually increased, typically by 100 mg three times daily, at intervals of one to two days, based on the patient's blood pressure response and symptomatic relief. The maximum recommended dose is usually 600 mg three times daily (1800 mg per day).

It is important to take Droxidopa consistently as prescribed. The last dose of the day should generally be taken at least three hours before bedtime to help mitigate the risk of supine hypertension, a condition where blood pressure becomes too high when lying down. Patients should be advised to take their medication with a full glass of water. Adherence to the prescribed dosing schedule and regular blood pressure monitoring are crucial for safe and effective treatment.

Side Effects

Like all medications, Droxidopa can cause side effects. The most common adverse reactions reported include headache, dizziness, nausea, hypertension (high blood pressure), and fatigue. It is crucial for patients to be aware of the potential for increased blood pressure, especially when lying down. This condition, known as supine hypertension, is a significant concern and requires careful monitoring.

Other potential side effects may include urinary tract infections, rash, anxiety, and bradycardia (slow heart rate). More serious, though less common, side effects can include severe hypertension, cardiac arrhythmias, and central nervous system effects such as confusion or hallucinations. Patients should be instructed to report any unusual or severe symptoms to their healthcare provider immediately. Regular blood pressure monitoring, both in standing and supine positions, is essential during Droxidopa treatment to manage and prevent adverse events.

Drug Interactions

Droxidopa's efficacy and safety can be influenced by interactions with other medications. It is vital for patients to inform their doctor about all prescription, over-the-counter, and herbal supplements they are taking. Key drug interactions to be aware of include:

• Monoamine Oxidase Inhibitors (MAOIs): These drugs can inhibit the metabolism of norepinephrine, potentially leading to dangerously high blood pressure when combined with Droxidopa.
• Tricyclic Antidepressants (TCAs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): These medications can enhance the pressor effects of Droxidopa, increasing the risk of hypertension.
• Other Adrenergic Agents: Concomitant use with other drugs that increase blood pressure (e.g., ephedrine, pseudoephedrine) can lead to additive pressor effects.
• Beta-Blockers: These drugs may attenuate the pressor response to Droxidopa, potentially reducing its effectiveness in raising blood pressure.
• Alpha-Adrenergic Antagonists: These medications can counteract the vasoconstrictive effects of norepinephrine, potentially reducing Droxidopa's efficacy.
• Alcohol: Alcohol can exacerbate orthostatic hypotension and may interact with Droxidopa, requiring caution.

Close monitoring of blood pressure and careful dose adjustments are necessary when Droxidopa is co-administered with any of these agents.

FAQ

What is the brand name for Droxidopa?

In the United States, Droxidopa is marketed under the brand name Northera.

How long does Droxidopa take to work?

Patients may start to experience some symptomatic relief within a few days of starting Droxidopa. However, the full therapeutic effect often requires careful dose titration over several days to weeks, as the optimal dose varies greatly among individuals.

Can Droxidopa cause high blood pressure?

Yes, Droxidopa can cause high blood pressure, particularly when lying down (supine hypertension). This is a known side effect and requires careful monitoring of blood pressure, especially before bedtime.

Who should not take Droxidopa?

Droxidopa is generally contraindicated in patients with pre-existing, uncontrolled supine hypertension or pheochromocytoma. It should be used with caution in patients with heart disease, kidney disease, or a history of stroke. Always consult your physician for personalized medical advice.

Is Droxidopa a stimulant?

While Droxidopa increases levels of norepinephrine, which is a stimulating neurotransmitter, it is not classified as a central nervous system stimulant in the same way as amphetamines or methylphenidate. Its primary action is on blood pressure regulation in the peripheral nervous system, not directly on brain activity for alertness or focus.

Products containing Droxidopa are available through trusted online pharmacies. You can browse Droxidopa-based medications at ShipperVIP or Medicenter.

Summary

Droxidopa is a vital medication for individuals suffering from symptomatic neurogenic orthostatic hypotension, a debilitating condition characterized by a significant drop in blood pressure upon standing. As a prodrug for norepinephrine, it helps to restore proper blood pressure regulation by increasing vasoconstriction, thereby alleviating symptoms like dizziness, lightheadedness, and fainting. While offering significant benefits in improving the quality of life for affected patients, its use requires careful medical supervision, precise dose titration, and vigilant monitoring for side effects, most notably supine hypertension. Understanding its mechanism, proper dosage, potential side effects, and drug interactions is crucial for optimizing therapeutic outcomes and ensuring patient safety. Always consult a healthcare professional for diagnosis and treatment of orthostatic hypotension.